A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Wang, Lijie, Zhang, Sujie, Chen, Guangying, Li, Xiaoyan, Cui, Pengfei, Zheng, Xuan, Hu, Yi
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/
https://ncbi.nlm.nih.gov/pubmed/33457011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi